Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 458,480 | 283,255 | 118,095 | 444,091 | 307,079 |
| Depreciation Amortization | 63,727 | 41,806 | 20,586 | 77,744 | 57,883 |
| Income taxes - deferred | 17,402 | -9,952 | -2,858 | 532 | 15,824 |
| Accounts receivable | -37,580 | -7,884 | 3,834 | -74,245 | -51,533 |
| Other Working Capital | -142,827 | -84,547 | 7,472 | -89,277 | -114,646 |
| Other Operating Activity | 73,327 | 31,254 | 7,092 | 120,219 | 85,990 |
| Operating Cash Flow | $432,529 | $253,932 | $154,221 | $479,064 | $300,597 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -247,355 | -3,121 | -89,472 | -252,027 | -596,157 |
| PPE Investments | 443,330 | -2,513 | -950 | -10,696 | 303,954 |
| Investing Cash Flow | $195,975 | $-5,634 | $-90,422 | $-262,723 | $-292,203 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -3,321 | N/A | N/A |
| Common Stock Issued | 17,683 | -302,287 | N/A | 31,139 | 27,554 |
| Common Stock Repurchased | -342,372 | N/A | N/A | -250,000 | N/A |
| Financing Cash Flow | $-324,689 | $-302,287 | $-3,321 | $-218,861 | $27,554 |
| Beginning Cash Position | 115,850 | 115,850 | 115,850 | 118,370 | 118,370 |
| End Cash Position | 419,665 | 61,861 | 176,328 | 115,850 | 154,318 |
| Net Cash Flow | $303,815 | $-53,989 | $60,478 | $-2,520 | $35,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | 432,529 | 253,932 | 154,221 | 479,064 | 300,597 |
| Capital Expenditure | -5,543 | -2,513 | -950 | -10,696 | -7,644 |
| Free Cash Flow | 426,986 | 251,419 | 153,271 | 468,368 | 292,953 |